This device was classified as the highest risk class 3 medical device. On top of that, they are seeking an approval for both the liver and pancreatic cancer applications. No wonder the near term could easily be 1-2 years, provided no further data/clarification needed
OSL Price at posting:
14.0¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)